November 20, 2017November 20, 2017

FDA Approves Fasenra for Severe Asthma Stemming from Immune Cell Glut

Asthma, News

The U.S. Food and Drug Administration has approved Fasenra (benralizumab) as an add-on maintenance treatment for people 12 years and older with severe asthma. In this case, the authorization is ... Read more

September 10, 2014November 6, 2015

Two GSK Phase III Studies of Mepolizumab For Severe Eosinophilic Asthma Show Promise

Asthma, News

A team of researchers at GSK recently presented the results from two-PHASE III Clinical Trials of Mepolizumab, a new humanized IL-5 antagonist monoclonal antibody, for the treatment of severe eosinophilic ... Read more